| #301 |
Charles E. Germanton |
— |
2 |
| #301 |
Maria Pasquale |
— |
2 |
| #301 |
Brian A. Leuthner |
Edge Therapeutics |
2 |
| #301 |
William S. Cleveland |
AT&T |
2 |
| #301 |
Alex Derchak |
Adidas Ag |
2 |
| #301 |
Agustin Izquierdo |
Basf Se |
2 |
| #301 |
Patrick Griffith |
Jbf Interlude 2009 |
2 |
| #301 |
George W. Halek |
Celanese Gmbh |
2 |
| #301 |
Horace C. Casey, Jr. |
Bell Telephone Laboratories |
2 |
| #301 |
Richard A. Rafferty |
Viscot Medical |
2 |
| #301 |
Jon T. Gieselman |
— |
2 |
| #301 |
Steve Greenblatt |
Liquidnet Holdings |
2 |
| #301 |
George DEStevens |
Ciba-Geigy |
2 |
| #301 |
Sudipta Ganguly |
Apple |
2 |
| #301 |
Leif Rongved |
Bell Telephone Laboratories |
2 |
| #301 |
Charles W. Kadlec |
Ameriprise Financial |
2 |
| #301 |
Leon M. Misiukiewicz |
Time Co. |
2 |
| #301 |
Puyun Guo |
Electrocore |
2 |
| #301 |
Christie Lewis Zipfel |
AT&T |
2 |
| #301 |
Richard J. Gurak |
International Telephone And Telegraph |
2 |
| #301 |
John R. Rhinelander |
JPMorgan Chase |
2 |
| #301 |
Stephen G. Seger, Jr. |
AT&T |
2 |
| #301 |
Angeli Alino Breen |
— |
2 |
| #301 |
Noah Frederick Breen |
— |
2 |
| #301 |
Yung-Shyeng Tsao |
Merck |
2 |
| #301 |
Griffin Michael Breen |
— |
2 |
| #301 |
Richard Viana |
Morgan Stanley |
2 |
| #301 |
Priya Dayananth |
Merck |
2 |
| #301 |
Keith Halper |
— |
2 |
| #301 |
Michael V. Chiarulli |
Disney |
2 |
| #301 |
Imre A. Halmos |
American Cyanamid |
2 |
| #301 |
Stanley R. Frankel |
Juno Therapeutics |
2 |
| #301 |
Jonathan Haim Saks |
Novell |
2 |
| #301 |
Andre K. Crump |
AT&T |
2 |
| #301 |
Martin Schorning |
Hoechst Celanese |
2 |
| #301 |
John E. Smethers |
Warner-Lambert Company |
2 |
| #301 |
David Tulsky |
Harcourt Assessment |
2 |
| #301 |
Stephen B. Schectman |
Schering |
2 |
| #301 |
Alana J. Simpson |
— |
2 |
| #301 |
Satish Bhatia |
Novartis Ag |
2 |
| #301 |
Louis R. Jeffrey, Jr. |
— |
2 |
| #301 |
Arthur G. Deacon |
AT&T |
2 |
| #301 |
Barry GERTZ |
Merck |
2 |
| #301 |
A Helen McGrath |
AT&T |
2 |
| #301 |
Barbara J. Hansbury |
— |
2 |
| #301 |
Krishna Adivi |
Intercontinental Great Brands |
2 |
| #301 |
Ida Aronchik |
Bristol-Myers Squibb |
2 |
| #301 |
Kellen Christopher Mollahan |
Joby Aero |
2 |
| #301 |
Brian Andrew Fox |
Immunexpress Pty |
2 |
| #301 |
Bruno Satkunas |
Dynamics Corporation Of America |
2 |